Michael W. Young’s Post

📢 Calling all life science tech enthusiasts! Join our Webinar Tuesday, March 27th at 10 AM PT! VisionSort: A New Dimension in Cell Analysis & Sorting #flowcytometry #Labelfree #AI #celltherapy #drugdiscovery #diseaseprofiling #cytometry

Respected connections, I feeling happy to say you that I had attended a 'National Conference' organised by Gupta College of Technological Sciences on topic "Recent Trends in Drug Development and Clinical Data management". I had participated in poster presentation on " Personalized Treatment of cancer by the Application of Artificial intelligence" under the guidance of Dr. Mithun Bhowmick sir, Dr. Pratibha Bhowmick mam and Soumik laha sir. #Posterpresentation #artificialintelligence #drugdevelopment

"Honored to have presented at the II Congress of BioMedLab on 'Biomarkers Development: From Exploratory Discovery to Clinical & Industry Impact'. Grateful for the invitation and impressed by the exceptional organization, speakers, and the massive turnout of 500 participants! A fantastic platform for advancing biomarker research. #BioMedLab #Biomarkers #Research #InnovativeClinicalTrials"

Really well received IQVIA session today at #wcp2023 on the continuing evolution in the use of genomics and multiple biomarkers in clinical trials - no longer the tools of tomorrow, these are the precision medicine tools of today! #weareiqvia #iqvia #iqviauk #clinicaltrials

We are progressing our first clinical program here at Auransa and with that, making some much needed updates to our company website! www.auransa.com I would encourage my network to look at our website where we describe our differentiated approach to mining massive, available and heterogeneous human disease data for therapeutic “gold,” using our AI platform, to raise the standard of cancer care. In the coming weeks I’ll be sharing more about our lead programs in #livercancer and heart-safe chemotherapy, which are progressing nicely, and our work with U.S. and global partners. #ai #drugdevelopment #livercancer #chemotherapy

We would like to share with you the insights of our founder, Igor Koman, regarding the questions about SmartOmica! How did you come up with the idea for Smartomica? Initially, the concept for Smartomica was raised around an Integrative Molecular Data analytical system to make comprehensive diagnostic solutions for advanced cancer patients. At that time we believed doctors may be interested in using such a tool as a part of their work with a patient. The reality did not prove this hypothesis which led to a switch in company focus from just developing IT tools to building a story around them. How does SmartOmica stay innovative and adaptive in the healthcare technology landscape? The unique competitive advantage of our company is in the competencies of our team. We succeed to unite exceptional medical doctors, young and passionate clinical researchers, experts in AI and data analysis, talented managers and entrepreneurs. The mutual expertise of our team allows us to be on the cutting edge of precision oncology and offer the most relevant solutions for our clients and patients. What has been the most rewarding moment or achievement in the company's journey so far? For me personally, the most rewarding moment was when the world-known medical doctor to whom we presented the results of Smartomica investigation for his patient aligned with our proposal and made a decision to stay with Smartomica as an external medical consultant. Indeed professional recognition and acceptance is the most challenging and sensitive issue for us, as we pioneer in the emerging field of precision oncology #PersonalizedMedicine #AI #Healthcare #Smartomica #BigDataOncology #OMICS #precisionmedicine #biotechnology